{"abstract": "The Deal Professor examines how Sanofi-Aventis could face a long fight with Genzyme over its hostile bid and how it needs to deal with the Genzyme board.", "web_url": "https://dealbook.nytimes.com/2010/10/04/what-sanofi-needs-to-win-genzyme/", "snippet": "The Deal Professor examines how Sanofi-Aventis could face a long fight with Genzyme over its hostile bid and how it needs to deal with the Genzyme board.", "lead_paragraph": "Sanofi-Aventis\u2019s hostile bid for Genzyme could be the start of a long fight between the French drug maker and its biotechnology target.", "source": "The New York Times", "multimedia": [], "headline": {"main": "What Sanofi Needs to Win Genzyme", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "persons", "value": "Icahn, Carl C", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Genzyme Corp", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Sanofi-Aventis SA", "rank": 4, "major": "N"}], "pub_date": "2010-10-04T18:30:48+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Steven Davidoff Solomon", "person": [{"firstname": "Steven", "middlename": "Davidoff", "lastname": "Solomon", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/340bc5c6-5bd7-52ea-97c8-f6d92d86f6a0", "word_count": 792, "uri": "nyt://article/340bc5c6-5bd7-52ea-97c8-f6d92d86f6a0"}